INTRODUCTION
The anti-inflammatory action of adrenal corticosteroid hormones is believed to be mediated in part by their This work was presented in part at the annual meeting of the American Rheumatism Association, June 1973, Los Angeles, Calif.
Received for publication 13 March 1974 and in revised form 5 June 1974. effects on lysosomal membranes. Early studies by de Duve, Wattiaux, and Wibo (1) and by Weissmann and Thomas (2) showed that hydrocortisone retarded the release of acid hydrolases from isolated lysosomes. Since the contents of these subcellular organelles can induce inflammation, inhibition of their release would modify and diminish the inflammatory process (3) . These observations, however, were based on studies with liver lysosomes, subcellular organelles not usually involved with extrahepatic inflammation. Recent studies using phagocytic cells and bactericidal systems have failed to document stabilization by hydrocortisone of the lysosomes in these cells (4) (5) (6) . Although Wright and Malawista (4) found less extracellular release of granular enzymes in 5 X 10' M cortisol, neither altered degranulation nor impaired intracellular digestion by lysosomal hydrolases was detected by Mandell, Rubin, and Hook (5) or by Wiener, Marmary, and Curelaru (6) . And no effects were observed by these authors using hydrocortisone in the usual physiologic and pharmacologic concentrations. Since the polymorphonuclear (PMN)1 leukocyte is the dominant cell in acute inflammatory reactions-reactions that can be suppressed by corticosteroids-we have studied the effect of adrenocortical hormones on lysosomes isolated from these cells.
METHODS
Intact leukocyte lysosomes were isolated from normal human venous blood PMN leukocytes by the method of Chodirker, Bock, and Vaughan (7) . Briefly, after hypotonic lysis of red cells in 0.2% saline and washing in 0.34 M sucrose, leukocytes (75-90% PMN) were disrupted by rapid pipetting in 0.2 M sucrose containing aqueous heparin, 50 U/ml. Intact large granules composed mainly of lysosomes were isolated by differential centrifugation (the organelles sedimenting between 800 g for 15 min and 25,000 g for 10 min), washed, and suspended in 0.3 M sucrose containing heparin so that the absorbance 520 nm of the suspension was 0.6-0. 8 (8) . Volumes used were 0.8 ml of lysosome suspension (Am nm = 0.6) and 0.1 ml steroid followed by 0.1 ml detergent, final concentration 0.01%o (vol/vol) . Absorbance was measured before the addition of detergent and at intervals of 60 s after its addition with rapid mixing.
To study the effect of in vivo adrenocorticosteroids, normal adult males received prednisolone by mouth, 60 mg/day in divided doses. After 3 days, venous blood PMN leukocyte lysosomes isolated from three steroid-treated individuals were pooled and stressed with heat incubation, and the liberated enzyme activity was quantitated as a percent of total enzyme content of the suspension. The results were contrasted with a lysosome suspension obtained from untreated controls. Six control subjects were needed to provide sufficient numbers of PMN leukocytes for these stress experiments. The absorbance of the organelle suspensions from both treated and control subjects was made identical before testing. In addition, sera obtained daily for 3 days before and during steroid administration were studied for their effects on detergent-stressed normal lysosomes. 0.1 ml of serum was mixed with 0.8 ml of the intact lysosome suspension before the addition of 0.1 ml of 0.1%o Triton X-100 and the absorbance change measured. This method for the detection of serum membrane reactants that modify organelle permeability has been previously described (9) (10) . A lysosomal stabilizer in the serum will retard the rate of absorbance change followed addition of the membranolytic detergent.
Activity of the lysosomal enzyme, 6-glucuronidase, was measured by the method of Fishman, Springer, and Brunetti (11) with phenolphthalein glucuronide as substrate.
The time of 370C incubation of 0.2-ml samples at pH 4.5 was 6 h. Absorbance 550 nm was determined after addition of glycine buffer, pH 10.4. Activity as determined by using a beef liver 8-glucuronidase standard (Nutritional Biochemicals Corporation, Cleveland, Ohio) showed one Fishman U = 0.0025 ODm .n/h at 370C. Acid phosphatase was determined by the method of Andersch and Szczpinski using p-nitrophenylphosphate as substrate (12) . The time of incubation at 370C, pH 4.8, of 0.2-ml samples was 5 h. Absorbance 420 nm was measured after addition of 0.1 N NaOH. 1 U of enzyme activity as standardized against wheat germ acid phosphatase (Sigma Chemical Co., St. Louis, Mo.) was 0.340 ODno nm/30 min at 370C.
Steroid hormones studied were 4-pregnene-11 8,17a,21-triol-3,20-dione (hydrocortisone) and 1,4-pregnadiene-17a,21-diol-3,11,20-trione (prednisone) from Sigma Chemical Co., hydrocortisone sodium succinate from Upjohn Co., Kalamazoo, Mich., 9ac-fluoro-16a-methylprednisolone (dexamethasone) from Merck & Co., Inc., Rahway, N. J., and hydrocortisone acetate, hydrocortisone hemisuccinate, 4-androstene-3,17-dione (androstenedione), and A4-pregnene-3,20-dione (progesterone) from Mann Research Labs Inc., New York. After solubilization in DMSO, all steroids were diluted in lysosomal buffers for use in lysosome stress tests. All compounds were studied at multiple dilutions for possible inhibitory effects on lysosome enzyme activities.
RESULTS
Incubation at 370C exerts a significant and reproducible stress on intact isolated human leukocyte lysosomes (Table I ). In the absence of steroid hormones, incubation for 90 min induced a release of 20% of the total P-glucuronidase and 19% of the total acid phosphatase contents of the lysosome suspension. Total content was determined by summing the activities present in the 0.3 M sucrose suspension after incubation and the enzyme content released by subsequent freezing and thawing of the remaining intact lysosomes. Cellular acid phosphatase from other than lysosomal sites was believed to account for the differences observed between the two enzymes assayed (13) . Because 8-glucuronidase is more localized to the large granule (lysosomal) fraction of PMN leukocytes (14) , this enzyme was considered the The effects of progesterone and of androstenedione, 10_-10v M, are shown in Fig. 1 . These steroids, neither oxygenated nor hydroxylated at the C-1l position, have previously been shown to induce membrane rupture and allow leakage of enzymes from liver lysosomes (15) . It can be seen that these steroids also labilize lysosomes from human PMN leukocytes. Almost the total lysosome content of P-glucuronidase was released after incubation with 10 M progesterone. The membranolytic effect was dose related both for progesterone and androstenedione. Neither steroid inhibited the enzyme measured.
The anti-inflammatory steroids previously shown to stabilize liver organelles, however, were not capable of retarding release of enzyme from PMN lysosomes (Fig.  2) . Hydrocortisone, dexamethasone, prednisone, and hydrocortisone sodium succinate did not prevent the release of P-glucuronidase from lysosomes stressed by heat incubation. These steroids were studied at various concentrations including the usual physiologic and pharmacologic ranges. Less of the lysosomal enzyme assayed was found in the supernate after incubation of the organelles with either hydrocortisone hemisuccinate or with hydrocortisone acetate, in concentrations ranging from 10 to 10' M. The activities of both of the soluble granulocyte lysosomal enzymes studied were inhibited by the addition of these two compounds, this effect being dose related. Thus, the finding of less enzyme in the supernate was due to enzyme inhibition by these corticosteroid preparations rather than to lysosomal membrane stabilization. In no case could any of the anti-inflammatory steroids studied be found to stabilize PMN leukocyte lysosomes to a statistically significant degree.
Lysosomes preincubated for 20 min at 230C with dexamethasone, 5 X 10' M, were then challenged with the labilizer, androstenedione, 5 X 10' M (Fig. 3) . After 370C incubation for 90 min, lysosomes released as much enzyme as when incubated in androstenedione alone. P-Glucuronidase release in dexamethasone alone did not differ from the control.
PMN leukocyte lysosomal membrane stabilization by an anti-inflammatory steroid was also investigated by a different stress technique (Fig. 4) . Hydrocortisone hemisuccinate at either 5 X 10 or 5 X 10-' M could not protect isolated organelles from the lytic effects of a nonionic detergent. A stabilizing agent would be expected to retard the change in absorbance of the lysosomal suspension after the addition of the membranolytic Triton X-100. In no case was the Amwm change of the steroid-treated lysosomes statistically different from controls.
Studies with an anti-inflammatory steroid (dexamethasone) and with a membrane labilizer (progesterone) were performed with normal rat liver as the lysosome source (Fig. 5) . Liver organelles contained in the subcellular fraction sedimenting between 1,000 g for 10 min and 25,000 g for 10 min were stressed with 370C incubation for 45 min (16) . This incubation period caused the liver organelles to leak 16.5±1.5% of their total enzyme content in the absence of steroid. Enzyme release was augmented by the PMN leukocyte lysosome labilizer, progesterone, at several concentrations. Unlike its action on PMN leukocyte lysosomes, however, dexamethasone prevented the release of P-glucuronidase from heatstressed liver organelles. Significantly less enzyme was detected at both 5 X 10' and 1 X 10' M concentrations, and dexamethasone did not inhibit the liver lysosomal enzyme studied.
Lysosomes isolated from normal human volunteers receiving prednisolone were stressed by heat incubation and the f-glucuronidase activity released was assayed. A simultaneously studied organelle suspension obtained from control subjects released 38.8±1.9% (SEM) of the total granule content of P-glucuronidase after incubation at 370C for 90 min. The lysosomes from steroidtreated volunteers released 37.9±2.9%. These values represent data obtained from five control and six steroid studies, each with three replicates. The plasma cortisol concentrations studied at the time PMN leukocytes were obtained averaged 14.7 ttg/100 ml in control subjects and 0.8 Ag/100 ml in volunteers receiving prednisolone.
Thus in vivo anti-inflammatory steroids did not render PMN leukocyte lysosomes more resistant to heat stress. Furthermore, serum obtained during prednisolone treatment did not protect isolated organelles from lysis by Triton X-100 (Fig. 6 ). Sera obtained from subjects receiving adrenocorticosteroid had the same effect as control sera. The membranolytic action of the detergent was not impeded. As anticipated, plasma cortisol concentrations were depressed by the exogenous prednisolone, indicating that the volunteers had ingested the steroid.
DISCUSSION
The methods used in these experiments are the techniques commonly employed to study the effects of steroid hormones on lysosomal membranes (1, 2, 8, 15, 16 (17, 18) have confirmed the stabilization hypothesis. Either no effect or mild stabilization has been noted with anti-inflammatory steroids, depending upon experimental conditions. These diverse observations have also been found using PMN leukocyte lysosomes. Thus, Weissmann, Becher, and Thomas (8) showed that 10" M hydrocortisone would not protect rabbit peritoneal PMN leukocyte lysosomes from streptolysin 0 lysis. And Willis, Davison, Ramwell, Brocklehurst, and Smith (19) could not alter the release of P-glucuronidase from isolated lysosomes by hydrocortisone even at concentrations up to 1 mg/ml. Both hydrocortisone and paramethasone were found to be without effect at 10-8-104 M on rat blood leukocyte lysosomes but capable of stabilizing rabbit and guinea pig peritoneal exudate PMN organelles using hypotonic incubation media (20, 21) .
The variables found by these authors to alter lysosomal membrane permeability have included species and organ sources of organelles, tonicity and pH of media, and the types of stress procedures employed. In addition, lysosomes from both liver (22) and PMN leukocytes (23, 24) are heterogeneous in composition and form. These variables could account for some of the published discrepancies on how drugs affect membrane stability. We used experimental conditions more physiologic for our studies with lysosomes. Whereas both liver and PMN leukocyte lysosomes can be labilized by progesterone and androstenedione, only liver organelles were stabilized by the anti-inflammatory steroids, and then to only a mild degree.
The reasons for the different reactivity of liver and PMN leukocyte lysosomes to anti-inflammatory corticosteroids are unclear; our observations could be due to variations in membrane structure. Although the studies performed thus far (25, 26) are in agreement concerning protein content (both liver and leukocyte organelle membranes containing approximately 50% protein/wet wt) differences have been found in the lipids of these membranes. Rat liver lysosomal membranes contained cholesterol and phospholipid at a ratio of 1: 3.4 (25) , and a cell membrane fraction from rabbit PMN leukocyte granules had a ratio of 1: 1.4 (26) . If steroids alter permeability by their action at the lipid-water interface of membranes, these differences in the composition of the membrane lipids could explain our results.
Using viable cell preparations, numerous authors, including Mandell, Rubin, and Hook (5) and Wiener et al. (6) , have shown that hydrocortisone prevents the release of lysosomal hydrolases during phagocytosis. This association with anti-inflammatory corticosteroids has also been observed with in vivo models of inflammation (27, 28) and lysosome rupture (29) . But direct membrane interaction by these compounds and resulting stabilization need not be invoked to explain their antiphlogistic actions. Corticosteroids have a wide range of biological activities that could account for their suppressive effects on inflammation (30) (31) (32) (33) (34) . Interference with glucose transport (33) and inhibition of ATP generation (34), or suppression of NADH oxidase activity (5) are several actions that could lead to depressed cell function. After phagocytosis, these effects of hydrocortisone would prevent the intracellular metabolic activity necessary for merger of organelle membranes with the endocytic vacuole, the subsequent degranulation, and the extrusion of lysosome contents from the cell. In light of our experimental observations presented above, these are more plausible explanations for the mechanism of anti-inflammatory steroid action than the hypothesis of direct membrane stabilization.
